Medical device company: EndoChoice Holdings (GI)-Delisting (2007)

EndoChoice Holdings, Inc. (NYSE:GI) was established in October 2007 and is headquartered in Alpharetta, Georgia, USA, with 418 full-time employees (3/31/2015). It is a company specializing in the design, production and sales of innovative gastrointestinal products. Medical device company.

Update: On September 27, 2016, Boston Scientific acquired EndoChoice for approximately US$210 million.

ECPM Holdings GI EndoChoice Logo

EndoChoice Holdings (GI) :

The predecessor of the company, EndoChoice, Inc., was founded in October 2007. In September 2012, ECPM Holdings, LLC was established and inherited all the assets of EndoChoice, Inc. and Peer Medical Ltd. in January 2013, both of which were Known as a wholly-owned subsidiary of ECPM Holdings. In January 2013, the company acquired RMS Endoskopie-Technik Stephan Wieth eK through the German subsidiary EndoChoice GmbH. Soon after, the company changed its name to EndoChoice Holdings, Inc..

ECPM Holdings (EndoChoice) is a company focused on the design and sales of gastrointestinal (GI) medical equipment. It is committed to building a platform for GI medical personnel. The company currently holds the US gastrointestinal (GI) surgery (endoscopic surgery) 1/ 3 markets, currently serving more than 2,500 GI institutions.

EndoChoice Holdings provides a full range of pathology and imaging system products and services, surpassing the traditional single equipment product. Starting in 2013, the company began the commercialization of the Fuse® full range of endoscopes. The Fuse® system has made gastrointestinal experts better than before. We can see more things after anatomy twice. It has been clinically proven that the Fuse® system can improve the detection effect of standard colonoscopy by more than 69% in detecting precancerous polyps.

EndoChoice Holdings (GI) investment:

EndoChoice Holdings (EndoChoice) is another cancer concept stock that provides services for cancer detection, and has listed products that can be paid attention to.

EndoChoice Holdings filed an IPO application with the SEC on May 5, 2015. It was listed and traded on June 5, 2015. The issue price was US$15. It issued 6.35 million shares and raised US$95.25 million. It was traded on the New York Stock Exchange, stock code: GI .

GI official website:

GI American Stock Encyclopedia:

Notify of
Inline Feedbacks
View all Intels

China Stocks: iKang Healthcare Group (KANG) (2000)

Swiss Army Knife Company: Victorinox&Wenger (true and false identification)